CCDC74B | Coiled-coil domain containing 74B | | | | | | Tissue enhanced |
CCDC89 | Coiled-coil domain containing 89 | | | | | | Tissue enhanced |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDC20B | Cell division cycle 20B | | | | | | Tissue enhanced |
CDH12 | Cadherin 12, type 2 (N-cadherin 2) | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CHRNA9 | Cholinergic receptor, nicotinic, alpha 9 (neuronal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CHST9 | Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNGB3 | Cyclic nucleotide gated channel beta 3 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CNTF | Ciliary neurotrophic factor | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CORO2B | Coronin, actin binding protein, 2B | Plasma proteins
| | | | | Tissue enhanced |
CRISP3 | Cysteine-rich secretory protein 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRTAC1 | Cartilage acidic protein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCAF12L1 | DDB1 and CUL4 associated factor 12-like 1 | | | | | | Tissue enhanced |
DCAF12L2 | DDB1 and CUL4 associated factor 12-like 2 | | | | | | Tissue enhanced |
DCDC1 | Doublecortin domain containing 1 | Cancer-related genes
| | | | | Tissue enhanced |
DEFB124 | Defensin, beta 124 | Predicted secreted proteins
| | | | | Tissue enhanced |
DENND6B | DENN/MADD domain containing 6B | | | | | | Tissue enhanced |
DNAH11 | Dynein, axonemal, heavy chain 11 | Disease related genes
| | | | | Tissue enhanced |
DNAH3 | Dynein, axonemal, heavy chain 3 | Plasma proteins
| | | | | Tissue enhanced |
DNAH5 | Dynein, axonemal, heavy chain 5 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DNAH6 | Dynein, axonemal, heavy chain 6 | Plasma proteins
| | | | | Tissue enhanced |
DNAH7 | Dynein, axonemal, heavy chain 7 | Plasma proteins
| | | | | Tissue enhanced |
DNALI1 | Dynein, axonemal, light intermediate chain 1 | | | | | | Tissue enhanced |
DTHD1 | Death domain containing 1 | | | | | | Tissue enhanced |
DYX1C1 | Dyslexia susceptibility 1 candidate 1 | Disease related genes
| | | | | Tissue enhanced |
EFCAB1 | EF-hand calcium binding domain 1 | | | | | | Tissue enhanced |
EFCAB12 | EF-hand calcium binding domain 12 | | | | | | Tissue enhanced |
EFHB | EF-hand domain family, member B | | | | | | Tissue enhanced |
EFHC2 | EF-hand domain (C-terminal) containing 2 | | | | | | Tissue enhanced |
EMX2 | Empty spiracles homeobox 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ENO4 | Enolase family member 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
EYA2 | Eyes absent homolog 2 (Drosophila) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
EYA4 | Eyes absent homolog 4 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
FAM154B | Family with sequence similarity 154, member B | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM179A | Family with sequence similarity 179, member A | | | | | | Tissue enhanced |
FAM187A | Family with sequence similarity 187, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM227A | Family with sequence similarity 227, member A | | | | | | Tissue enhanced |
FAM27B | Family with sequence similarity 27, member B | | | | | | Tissue enhanced |
FAM47E | Family with sequence similarity 47, member E | | | | | | Tissue enhanced |
FAM86B1 | Family with sequence similarity 86, member B1 | | | | | | Tissue enhanced |
FAM86B2 | Family with sequence similarity 86, member B2 | | | | | | Tissue enhanced |
FBXO36 | F-box protein 36 | | | | | | Tissue enhanced |
FGF14 | Fibroblast growth factor 14 | Disease related genes RAS pathway related proteins
| | | | | Tissue enhanced |
FOLR1 | Folate receptor 1 (adult) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJB7 | Gap junction protein, beta 7, 25kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GPR111 | G protein-coupled receptor 111 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR64 | G protein-coupled receptor 64 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRIN3B | Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GSTA3 | Glutathione S-transferase alpha 3 | Enzymes
| | | | | Tissue enhanced |